Welcome to LookChem.com Sign In|Join Free
  • or
2-bromo-4-chloropropiophenone is an organic compound that serves as an intermediate in various chemical reactions and processes. It is characterized by the presence of a bromine atom at the 2nd position and a chlorine atom at the 4th position on a propiophenone molecule, which is a derivative of benzophenone. This unique structure allows it to be a versatile building block in the synthesis of various organic compounds.

877-37-2

Post Buying Request

877-37-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

877-37-2 Usage

Uses

Used in Organic Synthesis:
2-bromo-4-chloropropiophenone is used as an intermediate in organic synthesis for the production of a wide range of chemical compounds. Its reactivity and functional groups make it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Laboratory Research and Development:
In the field of laboratory research and development, 2-bromo-4-chloropropiophenone is utilized as a key compound in the exploration of new chemical reactions and the development of innovative synthetic pathways. Its unique structure allows researchers to investigate its potential applications and properties in various chemical and biological systems.
Used in Chemical Production Processes:
2-bromo-4-chloropropiophenone is also employed in chemical production processes, where it serves as a crucial intermediate for the manufacturing of various industrial chemicals. Its role in these processes is essential for the efficient and cost-effective production of a diverse array of chemical products.

Synthesis

A solution of 15.9 g (0.1 mol) of bromine in 20 ml of chloroform is added dropwise to a solution of 16.8 g (0.1 mol) of 4'-chloropropiophenone in 100 ml of chloroform, in the presence of a small amount of aluminium chloride, and the mixture is stirred overnight. After filtration and evaporation of the filtrate, the crystalline residue is washed with petroleum ether. When dry, it melts at 75° C.

Check Digit Verification of cas no

The CAS Registry Mumber 877-37-2 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,7 and 7 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 877-37:
(5*8)+(4*7)+(3*7)+(2*3)+(1*7)=102
102 % 10 = 2
So 877-37-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H8BrClO/c1-6(10)9(12)7-2-4-8(11)5-3-7/h2-6H,1H3

877-37-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-bromo-1-(4-chlorophenyl)propan-1-one

1.2 Other means of identification

Product number -
Other names (2R)-2-bromo-1-(4-chlorophenyl)propan-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:877-37-2 SDS

877-37-2Synthetic route

4'-chloropropiophenone
6285-05-8

4'-chloropropiophenone

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
With bromine at 20℃; for 0.333333h;100%
Stage #1: 4'-chloropropiophenone With bromine In methanol at 20℃; for 0.166667h;
Stage #2: With hydrogen bromide In methanol; water for 110h; Inert atmosphere;
98%
With bromine; hydrogen bromide In methanol at 20℃; for 110h; Inert atmosphere;98%
α-bromopropionyl bromide
563-76-8

α-bromopropionyl bromide

chlorobenzene
108-90-7

chlorobenzene

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
Stage #1: chlorobenzene With aluminum (III) chloride In dichloromethane at 10 - 15℃; for 1h;
Stage #2: α-bromopropionyl bromide In dichloromethane at 20℃; for 16h;
Stage #3: With water In dichloromethane at 0℃;
95.5%
Stage #1: chlorobenzene With aluminum (III) chloride In dichloromethane at 10 - 15℃; for 1h;
Stage #2: α-bromopropionyl bromide In dichloromethane at 20℃; for 16h;
95.5%
With aluminium trichloride at 0℃; for 1.5h;91%
With aluminum (III) chloride In dichloromethane at 0 - 20℃; for 1h; Concentration; Inert atmosphere;74%
chlorobenzene
108-90-7

chlorobenzene

α-bromo-propionyl chloride

α-bromo-propionyl chloride

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
With aluminium trichloride
etheric solution of 2-diazo-1-<4-chloro-phenyl>-propanone-(1)

etheric solution of 2-diazo-1-<4-chloro-phenyl>-propanone-(1)

Conditions
ConditionsYield
With hydrogen bromide
2-bromo-1-(4-chlorophenyl)-1-propanone

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: carbon disulfide; AlCl3 / Erwaermen des Reaktionsgemisches
2: acetic acid; bromine
View Scheme
Multi-step reaction with 2 steps
1: aluminum (III) chloride / dichloromethane
2: bromine / dichloromethane
View Scheme
triphenylphosphine
603-35-0

triphenylphosphine

A

triphenyl[1-(4-chlorophenyl)-1-oxo-2-propyl]-phosphonium bromide
103458-84-0

triphenyl[1-(4-chlorophenyl)-1-oxo-2-propyl]-phosphonium bromide

B

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
In acetonitrile
4'-chloropropiophenone
6285-05-8

4'-chloropropiophenone

aluminum chlorid

aluminum chlorid

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
With bromine In chloroform
4'-chloropropiophenone
6285-05-8

4'-chloropropiophenone

4-chloro-α-(3-isobutyl-1,2,4-triazol-1-yl)-propiophenone

4-chloro-α-(3-isobutyl-1,2,4-triazol-1-yl)-propiophenone

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
In diethyl ether; bromine
4'-chloropropiophenone
6285-05-8

4'-chloropropiophenone

2-(2,6-dichloro-phenyl)-6-(4,5-diphenyl-oxazol-2-yl)-1H-benzoimidazole
1137670-77-9

2-(2,6-dichloro-phenyl)-6-(4,5-diphenyl-oxazol-2-yl)-1H-benzoimidazole

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
With hydrogen bromide; bromine In dichloromethane for 0.25h;
4-Cyanochlorobenzene
623-03-0

4-Cyanochlorobenzene

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: iodine; magnesium / diethyl ether / Inert atmosphere
1.2: 6 h / Reflux
1.3: Heating
2.1: bromine / diethyl ether / 20 °C / Cooling with ice
View Scheme
4-chloro-N-methoxy-N-methylbenzamide
122334-37-6

4-chloro-N-methoxy-N-methylbenzamide

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: diethyl ether / 3 h / 0 °C
2: acetic acid; hydrogen bromide; bromine / 1 h
View Scheme
para-chlorobenzoic acid
74-11-3

para-chlorobenzoic acid

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 4-methyl-morpholine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride / dichloromethane / 12 h / 0 °C
2: diethyl ether / 3 h / 0 °C
3: acetic acid; hydrogen bromide; bromine / 1 h
View Scheme
4'-chloropropiophenone
6285-05-8

4'-chloropropiophenone

thiourea
17356-08-0

thiourea

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
With copper(ll) bromide In ethanol for 2h; Reflux;
1-(4-chlorophenyl)-1-propanol
13856-85-4

1-(4-chlorophenyl)-1-propanol

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
With N-Bromosuccinimide In tetrahydrofuran at 20℃;
bromochlorobenzene
106-39-8

bromochlorobenzene

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: magnesium; iodine / tetrahydrofuran / 20 °C / Inert atmosphere
1.2: 0 °C / Inert atmosphere
2.1: N-Bromosuccinimide / tetrahydrofuran / 20 °C
View Scheme
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

N,N-Dimethylammonium-N,N-dimethyldithiocarbamat

N,N-Dimethylammonium-N,N-dimethyldithiocarbamat

Dimethyl-dithiocarbamic acid 2-(4-chloro-phenyl)-1-methyl-2-oxo-ethyl ester
83363-05-7

Dimethyl-dithiocarbamic acid 2-(4-chloro-phenyl)-1-methyl-2-oxo-ethyl ester

Conditions
ConditionsYield
In methanol for 3h; Heating;97%
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

tert-butylamine
75-64-9

tert-butylamine

2-(N-tert-butylamino)-4'-chloropropiophenone
252193-58-1

2-(N-tert-butylamino)-4'-chloropropiophenone

Conditions
ConditionsYield
at 75℃; for 1.5h;97%
at 75℃; for 1.5h;97%
In acetonitrile at 60℃; Kinetics;
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

thiourea
17356-08-0

thiourea

2-amino-4-(4’-chlorophenyl)-5-methyl-1,3-thiazole
82632-77-7

2-amino-4-(4’-chlorophenyl)-5-methyl-1,3-thiazole

Conditions
ConditionsYield
With 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene on polystyrene.HL In tetrahydrofuran for 24h; Cyclization; Heating;94%
In ethanol for 2h; Reflux;
Reflux;
In ethanol Hantzsch Thiazole Synthesis; Reflux;
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

1-(4-chloro-3-nitrophenyl)-2-bromopropan-1-one
1151820-83-5

1-(4-chloro-3-nitrophenyl)-2-bromopropan-1-one

Conditions
ConditionsYield
With nitric acid at -20℃; for 0.25h;93.5%
With nitric acid at -20℃; for 0.25h;93.5%
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

3-methyl-phenol
108-39-4

3-methyl-phenol

1-(4-Chloro-phenyl)-2-m-tolyloxy-propan-1-one
74228-91-4

1-(4-Chloro-phenyl)-2-m-tolyloxy-propan-1-one

Conditions
ConditionsYield
With potassium carbonate In acetone for 5h; Heating;92.5%
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

malononitrile
109-77-3

malononitrile

2-amino-5-(4'-chlorophenyl)furan-3-carbonitrile
26454-85-3

2-amino-5-(4'-chlorophenyl)furan-3-carbonitrile

Conditions
ConditionsYield
With diethylamine In DMF (N,N-dimethyl-formamide) at 0 - 40℃; for 3.5h;91%
p-cresol
106-44-5

p-cresol

2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

1-(4-Chloro-phenyl)-2-p-tolyloxy-propan-1-one
74228-89-0

1-(4-Chloro-phenyl)-2-p-tolyloxy-propan-1-one

Conditions
ConditionsYield
With potassium carbonate In acetone for 5h; Heating;90.5%
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

3-phenylisoquinoline-1(2H)-thione

3-phenylisoquinoline-1(2H)-thione

2-(3-phenylisoquinolin-1-ylthio)-1-(4-chlorophenyl)propan-1-one

2-(3-phenylisoquinolin-1-ylthio)-1-(4-chlorophenyl)propan-1-one

Conditions
ConditionsYield
In ethanol at 50℃; for 2h; Inert atmosphere;89%
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

potassium thioacyanate
333-20-0

potassium thioacyanate

3,5-dimethylaminoaniline
108-69-0

3,5-dimethylaminoaniline

4‐(4‐chlorophenyl)‐N‐(3,5‐dimethylphenyl)‐5‐methyl‐1,3‐thiazol‐2‐amine
1321959-85-6

4‐(4‐chlorophenyl)‐N‐(3,5‐dimethylphenyl)‐5‐methyl‐1,3‐thiazol‐2‐amine

Conditions
ConditionsYield
Stage #1: 2-bromo-1-(4-chlorophenyl)-1-propanone; potassium thioacyanate In methanol at 20℃; for 0.5h; modified Hantzsch thiazole synthesis;
Stage #2: 3,5-dimethylaminoaniline In methanol modified Hantzsch thiazole synthesis; Reflux;
87%
2-bromo-1-(4-chlorophenyl)-1-propanone
877-37-2

2-bromo-1-(4-chlorophenyl)-1-propanone

potassium thioacyanate
333-20-0

potassium thioacyanate

aniline
62-53-3

aniline

4-(4-chlorophenyl)-5-methyl-N-phenylthiazol-2-amine
298219-06-4

4-(4-chlorophenyl)-5-methyl-N-phenylthiazol-2-amine

Conditions
ConditionsYield
Stage #1: 2-bromo-1-(4-chlorophenyl)-1-propanone; potassium thioacyanate In methanol at 20℃; for 0.5h; modified Hantzsch thiazole synthesis;
Stage #2: aniline In methanol modified Hantzsch thiazole synthesis; Reflux;
86%

877-37-2Relevant academic research and scientific papers

Discovery of the Oxadiazine FRM-024: A Potent CNS-Penetrant Gamma Secretase Modulator

Acharya, Raksha,Blain, Jean-Fran?ois,Burnett, Duane A.,Bursavich, Matthew G.,Costa, Donald E.,Freeman, Emily A.,Harrison, Bryce A.,Hrdlicka, Lori A.,Jin, Hong,Kapadnis, Sudarshan,Koenig, Gerhard,Moffit, Jeffrey S.,Murphy, Deirdre,Nolan, Scott J.,Patzke, Holger,Tang, Cuyue,Van Voorhies, Hilliary E.,Wen, Melody

, p. 14426 - 14447 (2021/10/12)

The recent approval of aducanumab for Alzheimer's disease has heightened the interest in therapies targeting the amyloid hypothesis. Our research has focused on identification of novel compounds to improve amyloid processing by modulating gamma secretase activity, thereby addressing a significant biological deficit known to plague the familial form of the disease. Herein, we describe the design, synthesis, and optimization of new gamma secretase modulators (GSMs) based on previously reported oxadiazine 1. Potency improvements with a focus on predicted and measured properties afforded high-quality compounds further differentiated via robust Aβ42 reductions in both rodents and nonhuman primates. Extensive preclinical profiling, efficacy studies, and safety studies resulted in the nomination of FRM-024, (+)-cis-5-(4-chlorophenyl)-6-cyclopropyl-3-(6-methoxy-5-(4-methyl-1H-imidazole-1-yl)pyridin-2-yl)-5,6-dihydro-4H-1,2,4-oxadiazine, as a GSM preclinical candidate for familial Alzheimer's disease.

Structural spectroscopic study of enantiomerically pure synthetic cathinones and their major metabolites

Spálovská, Dita,Pa?kan, Martin,Jurásek, Bronislav,Kucha?, Martin,Kohout, Michal,Setni?ka, Vladimír

supporting information, p. 850 - 860 (2021/01/25)

New psychoactive substances (NPSs) have become a popular alternative to illicit drugs of abuse. However, to determine their metabolic pathways in the human organism, a detailed knowledge of their structure is crucial. Here, we present a comprehensive spectroscopic structural study of synthetic cathinones (clephedrone, flephedrone, and brephedrone) and their major human metabolites, desmethyl derivatives. Chiral high-performance liquid chromatography was utilized to obtain the individual enantiomers of the parent synthetic cathinones and their assumed major metabolites synthesized de novo. The developed chromatographic method made it possible to obtain the target optically pure substances on a multimilligram scale. Electronic and vibrational circular dichroism, combined with infrared and ultraviolet spectroscopy and supported by DFT calculations, were used to determine their absolute configuration and the chiroptical methods to elucidate their molecular structure in detail. Two stable conformers of each substance were found in aqueous solution. Their relative abundances were estimated based on the Boltzmann distribution and the population weighted spectra were obtained. Very good agreement was achieved between the experimental and simulated spectra, enabling the 3D structures of the studied substances to be determined in aqueous solution. This journal is

Enantioselective Synthesis of Nitrogen-Nitrogen Biaryl Atropisomers via Copper-Catalyzed Friedel-Crafts Alkylation Reaction

Guo, Chang-Qiu,Liu, Ren-Rong,Lu, Chuan-Jun,Wang, Xiao-Mei,Xu, Qi,Zhang, De-Bing,Zhang, Peng

supporting information, p. 15005 - 15010 (2021/09/30)

Nitrogen-nitrogen bonds containing motifs are ubiquitous in natural products and bioactive compounds. However, the atropisomerism arising from a restricted rotation around an N-N bond is largely overlooked. Here, we describe a method to access the first enantioselective synthesis of N-N biaryl atropisomers via a Cu-bisoxazoline-catalyzed Friedel-Crafts alkylation reaction. A wide range of axially chiral N-N bisazaheterocycle compounds were efficiently prepared in high yields with excellent enantioselectivities via desymmetrization and kinetic resolution. Heating experiments showed that the axially chiral bisazaheterocycle products have high rotational barriers.

Novel benzene-based carbamates for ache/bche inhibition: Synthesis and ligand/structure-oriented sar study

Bak, Andrzej,Kozik, Violetta,Kozakiewicz, Dariusz,Gajcy, Kamila,Strub, Daniel Jan,Swietlicka, Aleksandra,Stepankova, Sarka,Imramovsky, Ales,Polanski, Jaroslaw,Smolinski, Adam,Jampilek, Josef

, (2019/05/10)

A series of new benzene-based derivatives was designed, synthesized and comprehensively characterized. All of the tested compounds were evaluated for their in vitro ability to potentially inhibit the acetyl-and butyrylcholinesterase enzymes. The selectivity index of individual molecules to cholinesterases was also determined. Generally, the inhibitory potency was stronger against butyryl-compared to acetylcholinesterase; however, some of the compounds showed a promising inhibition of both enzymes. In fact, two compounds (23, benzyl ethyl(1-oxo-1-phenylpropan-2-yl)carbamate and 28, benzyl (1-(3-chlorophenyl)-1-oxopropan-2-yl) (methyl)carbamate) had a very high selectivity index, while the second one (28) reached the lowest inhibitory concentration IC50 value, which corresponds quite well with galanthamine. Moreover, comparative receptor-independent and receptor-dependent structure–activity studies were conducted to explain the observed variations in inhibiting the potential of the investigated carbamate series. The principal objective of the ligand-based study was to comparatively analyze the molecular surface to gain insight into the electronic and/or steric factors that govern the ability to inhibit enzyme activities. The spatial distribution of potentially important steric and electrostatic factors was determined using the probability-guided pharmacophore mapping procedure, which is based on the iterative variable elimination method. Additionally, planar and spatial maps of the host–target interactions were created for all of the active compounds and compared with the drug molecules using the docking methodology.

Design, synthesis and broad-spectrum Bcr-Abl inhibitory activity of novel thiazolamide-benzamide derivatives

Liu, Juan,Huang, Honglin,Deng, Xiangping,Xiong, Runde,Cao, Xuan,Tang, Guotao,Wu, Xin,Xu, Shiyu,Peng, Junmei

, p. 2092 - 2101 (2019/01/26)

Bcr-Abl plays an important role in the pathogenesis and development of chronic myeloid leukemia (CML). But Bcr-Abl is prone to mutation, so it increases the difficulty of clinical treatment. Therefore, it is crucial to design a new class of broad-spectrum Bcr-Abl inhibitors. Herein, forty novel thiazolamide-benzamide derivatives were synthesized and evaluated their broad-spectrum Bcr-Abl inhibitory activities. The newly synthesized compounds were characterized by using spectrum data (1H NMR, APCI-MS and IR) and elemental analysis. The protein kinase results indicated that eight compounds (3a, 3e, 3m, 3n, 3p, 4c, 4f, 4g) showed high activities to wild-type and T315I mutation. The most potent compound 3m exhibited an Abl IC50 value as low as 1.273 μM and showed inhibition to the T315I mutant with IC50 value 39.89 μM. 3m could prove to be a new promising lead compound for the further development of broad-spectrum Bcr-Abl inhibitors to overcome clinical acquired resistance.

Synthesis of α,β-dibromo ketones by photolysis of α-bromo ketones with N-bromosuccinimide: Photoinduced β-bromination of α-bromo ketones

Moon, Da Yoon,An, Sejin,Park, Bong Ser

, (2019/10/28)

Irradiation of α-bromopropiophenones in the presence of NBS results in the formation of α,β-dibromopropiophenones, which can be viewed as β-bromination of α-bromopropiophenones. The reaction is believed to go through a series of reactions; photoinduced C–Br bond cleavage, elimination of HBr to give α,β-unsaturated ketone intermediates, and addition of Br2, which are formed by the reaction between HBr and NBS. From mechanistic studies of the reaction, we have also found a very convenient method for α-debromination of the α,β-dibromopropiophenones which is by simple irradiation of the dibromo ketones in acetone or 2-propanol without the use of any additives. Our results demonstrate that bromine can be added into or eliminated from the alpha, beta, or both positions to the carbonyl group by photochemical methods, which make synthetic options of bromine containing carbonyl compounds versatile.

NBS-mediated synthesis of β-keto sulfones from benzyl alcohols and sodium arenesulfinates

Muneeswara, Madithedu,Sundaravelu, Nallappan,Sekar, Govindasamy

, p. 3479 - 3484 (2019/05/21)

An efficient synthetic route towards the synthesis of β-keto sulfones has been developed from secondary benzyl alcohols using N-bromosuccinimide (NBS). The present protocol utilizes NBS as oxidant as well as brominating agent, readily accessible benzyl alcohols and sodium arenesulfinates as the sulfonylating reagent under mild conditions. The control experiments revealed that the reaction proceeds via oxidation of alcohol to ketone, α-bromination of ketone and nucleophilic substitution by sodium arenesulfinate. Furthermore, the efficiency of the methodology was tested with a gram scale reaction and also shown the synthetic utility.

Formal Total Synthesis of Hybocarpone Enabled by Visible-Light-Promoted Benzannulation

Chen, Wei,Guo, Renyu,Yang, Zhen,Gong, Jianxian

, p. 15524 - 15532 (2019/01/03)

The formal total synthesis of hybocarpone was achieved in eight steps from commercially available 1,2,4-trimethoxybenzene. Key transformations include a visible-light-promoted benzannulation to construct the key α-naphthol intermediate and a modified CAN-mediated dimerization/hydration cascade sequence to generate the vicinal all-carbon quaternary centers in a stereocontrolled manner. The total synthesis of boryquinone was also achieved in seven steps.

INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS

-

Paragraph 0453; 0454, (2018/04/21)

The present disclosure relates to compounds and a pharmaceutically acceptable salt thereof, compositions, combinations and medicaments containing the compounds, and processes for their preparation. The disclosure also relates to the use of the compounds, combinations, compositions and medicaments, for example as inhibitors of the activity of the estrogen receptor, including degrading the estrogen receptor, the treatment of diseases and conditions mediated by the estrogen receptor.

Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools

Liessi, Nara,Cichero, Elena,Pesce, Emanuela,Arkel, Maria,Salis, Annalisa,Tomati, Valeria,Paccagnella, Matteo,Damonte, Gianluca,Tasso, Bruno,Galietta, Luis J.V.,Pedemonte, Nicoletta,Fossa, Paola,Millo, Enrico

, p. 179 - 200 (2017/12/28)

The most common CF mutation, F508del, impairs the processing and gating of CFTR protein. This deletion results in the improper folding of the protein and its degradation before it reaches the plasma membrane of epithelial cells. Present correctors, like VX809 only induce a partial rescue of the mutant protein. Our previous studies reported a class of compounds, called aminoarylthiazoles (AATs), featuring an interesting activity as correctors. Some of them show additive effect with VX809 indicating a different mechanism of action. In an attempt to construct more interesting molecules, it was thought to generate chemically hybrid compounds, blending a portion of VX809 merged to the thiazole scaffold. This approach was guided by the development of QSAR analyses, which were performed based on the F508del correctors so far disclosed in the literature. This strategy was aimed at exploring the key requirements turning in the corrector ability of the collected derivatives and allowed us to derive a predictive model guiding for the synthesis of novel hybrids as promising correctors. The new molecules were tested in functional and biochemical assays on bronchial CFBE41o-cells expressing F508del-CFTR showing a promising corrector activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 877-37-2